Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS–TEN overlap and potential drug–drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital

References

• LeeHYChungWHToxic epidermal necrolysis: the year in reviewCurr Opin Allergy Clin Immunol201313433033623799330
   PubMed Web of Science ®Google Scholar
• MockenhauptMSevere drug-induced skin reactions: clinical pattern, diagnostics and therapyJ Dtsch Dermatol Ges20097214216019371237
   PubMed Web of Science ®Google Scholar
• SchwartzRAMcDonoughPHLeeBWToxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesisJ Am Acad Dermatol2013692e171e113
   Web of Science ®Google Scholar
• ChanHLSternRSArndtKAThe incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatientsArch Dermatol1990126143472404462
   PubMedGoogle Scholar
• GerullRNelleMSchaibleTToxic epidermal necrolysis and Stevens-Johnson syndrome: a reviewCrit Care Med20113961521153221358399
   PubMed Web of Science ®Google Scholar
• NaveenKNPaiVVRaiVAthanikarSBRetrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, IndiaIndian J Pharmacol2013451808223543919
   PubMed Web of Science ®Google Scholar
• RzanyBMockenhauptMStockerUHamoudaOSchopfEIncidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in GermanyArch Dermatol1993129810598352614
   PubMedGoogle Scholar
• MockenhauptMViboudCDunantAStevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-studyJ Invest Dermatol20081281354417805350
   PubMed Web of Science ®Google Scholar
• SassolasBHaddadCMockenhauptMALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysisClin Pharmacol Ther2010881606820375998
   PubMed Web of Science ®Google Scholar
• BarvaliyaMSanmukhaniJPatelTPaliwalNShahHTripathiCDrug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective studyJ Postgrad Med201157211511921654132
   PubMed Web of Science ®Google Scholar
• Garcia-DovalILeCleachLBocquetHOteroXLRoujeauJCToxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?Arch Dermatol2000136332332710724193
   PubMedGoogle Scholar
• Indonesian Statistical Agency [webpage on the Internet]Population and Gender by Regency and City in West Java Province 20152015 Available from: http://jabar.bps.go.id/linkTableDinamis/view/id/12Accessed October 15th, 2016
   Google Scholar
• Indonesian Statistical AgencyUpdates on Indonesian Socio-Economics Main IndicatiorJakartaIndonesian Statistical Agency2013
   Google Scholar
• The World Bank [webpage on the Internet]PPP conversion factor, GDP (LCU per international $) Available from: http://data.worldbank.org/indicator/PA.NUS.PPP?page=2Accessed July 1, 2015
   Google Scholar
• RamosGVGuaraldoLJapiassuAMBozzaFAComparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical careJ Clin Pharm Ther2015401636725329640
   PubMed Web of Science ®Google Scholar
• ArenellaCYoxSEcksteinDSOusleyAExpanding the reach of a cancer palliative care curriculum through web-based dissemination: a public-private collaborationJ Cancer Educ201025341842120237885
   PubMed Web of Science ®Google Scholar
• YamaneYAiharaMIkezawaZAnalysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006Allergol Int200756441942517713361
   PubMedGoogle Scholar
• HalevySGhislainPDMockenhauptMAllopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and IsraelJ Am Acad Dermatol2008581253217919772
   PubMed Web of Science ®Google Scholar
• GueudryJRoujeauJCBinaghiMSoubraneGMuraineMRisk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysisArch Dermatol2009145215716219221260
   PubMedGoogle Scholar
• SakaBBarro-TraoreFAtadokpedeFAStevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countriesInt J Dermatol201352557557923330601
   PubMed Web of Science ®Google Scholar
• Mame ThiernoDOnSThierno NdiayeSNdiayeBSyndrome de Lyell au Sénégal: responsabilité de la thiacétazone [Lyell syndrome in Senegal: responsibility of thiacetazone]Ann Dermatol Venereol20011281213051307 French11908132
   PubMedGoogle Scholar
• TangamornsuksanWChaiyakunaprukNSomkruaRLohitnavyMTassaneeyakulWRelationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysisJAMA Dermatol201314991025103223884208
   PubMed Web of Science ®Google Scholar
• YuliwulandariRKashiwaseKNakajimaHPolymorphisms of HLA genes in Western Javanese (Indonesia): close affinities to Southeast Asian populationsTissue Antigens2009731465319140832
   PubMedGoogle Scholar
• AlrashoodSTCarbamazepineProfiles Drug Subst Excip Relat Methodol20164113332126940169
   PubMedGoogle Scholar
• WhiteTJArakelianARhoJPCounting the costs of drug-related adverse eventsPharmacoeconomics199915544545810537962
   PubMed Web of Science ®Google Scholar
• BordetRGautierSLe LouetHDupuisBCaronJAnalysis of the direct cost of adverse drug reactions in hospitalised patientsEur J Clin Pharmacol2001561293594111317484
   PubMed Web of Science ®Google Scholar
• DaviesECGreenCFTaylorSWilliamsonPRMottramDRPirmohamedMAdverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesPLoS One200942e443919209224
   PubMed Web of Science ®Google Scholar
• RoongpisuthipongWPrompongsaSKlangjareonchaiTRetrospective analysis of corticosteroid treatment in Stevens-Johnson Syndrome and/or toxic epidermal necrolysis over a period of 10 years in Vajira Hospital, Navamindradhiraj University, BangkokDermatol Res Prac20142014237821
   PubMedGoogle Scholar
• DilokthornsakulPSawangjitRInprasongCHealthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in ThailandJ Postgrad Med201662210911427089110
   PubMed Web of Science ®Google Scholar
• SunJLiuJGongQLStevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People’s Republic of ChinaDrug Des Devel Ther2014825392547
   PubMed Web of Science ®Google Scholar
• KimPSGoldfarbIWGaisfordJCSlaterHStevens-Johnson syndrome and toxic epidermal necrolysis: a pathophysiologic review with recommendations for a treatment protocolJ Burn Care Rehabil19834291100
   Google Scholar
• HalebianPHCorderVJMaddenMRFinklesteinJLShiresGTImproved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroidsAnn Surg198620455035123767483
   PubMed Web of Science ®Google Scholar
• MurphyJTPurdueGFHuntJLToxic epidermal necrolysisJ Burn Care Rehabil19971854174209313122
   PubMedGoogle Scholar
• KardaunSHJonkmanMFDexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysisActa Derm Venereol200787214414817340021
   PubMed Web of Science ®Google Scholar
• JagadeesanSSobhanakumariKSadanandanSMLow dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 casesIndian J Dermatol Venereol Leprol201379450651123760320
   PubMed Web of Science ®Google Scholar
• KhaliqYZhanelGGFluoroquinolone-associated tendinopathy: a critical review of the literatureClin Infect Dis200336111404141012766835
   PubMed Web of Science ®Google Scholar
• StjernholmMRKatzFHEffects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinateJ Clin Endocrinol Metab19754158878931184723
   PubMed Web of Science ®Google Scholar
• AssanRFredjGLargerEFeutrenGBismuthHFK 506/fluconazole interaction enhances FK 506 nephrotoxicityDiabete Metab199420149527520007
   PubMed Web of Science ®Google Scholar
• SinofskyFEPasqualeSAThe effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptivesAm J Obstet Gynecol199817823003049500490
   PubMed Web of Science ®Google Scholar
• HilbertJMessigMKuyeOFriedmanHEvaluation of interaction between fluconazole and an oral contraceptive in healthy womenObstet Gynecol200198221822311506836
   PubMed Web of Science ®Google Scholar
• Bastuji-GarinSRzanyBSternRSShearNHNaldiLRoujeauJCClinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeArch Dermatol1993129192968420497
   PubMedGoogle Scholar